Results 41 to 50 of about 1,747,273 (202)

Honey as an antiviral agent against respiratory syncytial virus [PDF]

open access: yes, 2011
Respiratory syncytial virus is the most frequent cause of hospitalization for viral respiratory infections in infants and young children worldwide. It also severely affects immunocompromised adults and the elderly, however, despite decades of efforts ...
Zareie, Parvaneh Palma
core  

A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus [PDF]

open access: yes, 2010
Human and bovine respiratory syncytial viruses (HRSV and BRSV) are two closely related, worldwide prevalent viruses that are the leading cause of severe airway disease in children and calves, respectively.
Dubuquoy, Catherine, C.   +18 more
core   +1 more source

Incidence and risk factors for respiratory syncytial virus and human metapneumovirus infections among children in the remote highlands of Peru [PDF]

open access: yes, 2015
The disease burden and risk factors for respiratory syncytial virus (RSV) and human metapneumovirus (MPV) infections among children living in remote, rural areas remain unclear.; We conducted a prospective, household-based cohort study of children aged ...
Gil, Ana I.   +48 more
core   +2 more sources

Modeling household dynamics on Respiratory Syncytial Virus (RSV) [PDF]

open access: yesPLOS ONE, 2019
Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past decades, namely fewer births, more elderly population,
Mahikul, W   +7 more
openaire   +4 more sources

Prevalence of human respiratory syncytial virus circulating in Iran

open access: yesJournal of Infection and Public Health, 2016
Summary: Respiratory syncytial virus (RSV) is a leading cause of acute respiratory infection during early childhood and is associated with a great burden on patients, parents, and society.
Vahid Salimi   +4 more
doaj   +1 more source

IRIS: Infection with RespIratory Syncytial Virus in infants—a prospective observational cohort study

open access: yesBMC Pulmonary Medicine, 2022
Background Respiratory syncytial virus (RSV) is the most common cause of acute lower respiratory tract infection in infants. Globally, RSV is responsible for approximately 3.2 million hospital admissions and about 60,000 in-hospital deaths per year ...
Martin Wetzke   +11 more
doaj   +1 more source

Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies

open access: yesInfection and Drug Resistance, 2023
Julia Dvorkin,1,2 Julián De Luca,1 Damian Alvarez-Paggi,1,2 Mauricio T Caballero1,2 1Fundación INFANT, Buenos Aires, Argentina; 2Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, ArgentinaCorrespondence: Mauricio T ...
Dvorkin J   +3 more
doaj  

Vaccination by microneedle patch with inactivated respiratory syncytial virus and monophosphoryl lipid A enhances the protective efficacy and diminishes inflammatory disease after challenge. [PDF]

open access: yesPLoS ONE, 2018
Intramuscular (IM) vaccination with formalin-inactivated respiratory syncytial virus (FI-RSV) failed in clinical trials due to vaccine-enhanced respiratory disease.
Soojin Park   +10 more
doaj   +1 more source

The Changing Landscape of Respiratory Syncytial Virus Infections

open access: yesPathogens, 2023
Respiratory syncytial virus (RSV), a negative-sense, enveloped RNA virus of the family Paramyxoviridae, subfamily Pneumovirinae, and genus Pneumovirus, is the single most important respiratory pathogen affecting infants and young children [...]
Reinout A. Bem, Job B. M. van Woensel
doaj   +1 more source

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

open access: yesNature Communications, 2016
Development of a safe and efficacious vaccine for respiratory syncytial virus (RSV) has been challenging. Here the authors generate a live-attenuated RSV vaccine that shows increased thermostability and immunogenicity, and protects cotton rats from RSV ...
Christopher C. Stobart   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy